phosphonoacetic acid has been researched along with ureidosuccinic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Foote, J; Schachman, HK | 1 |
Farrington, GK; Kumar, A; Wedler, FC | 1 |
Casper, ES; Gralla, RJ; Kemeny, N; Wiley, RG | 1 |
Brinster, RL; Troike, DE | 1 |
4 other study(ies) available for phosphonoacetic acid and ureidosuccinic acid
Article | Year |
---|---|
Homotropic effects in aspartate transcarbamoylase. What happens when the enzyme binds a single molecule of the bisubstrate analog N-phosphonacetyl-L-aspartate?
Topics: Adenosine Triphosphate; Allosteric Site; Antineoplastic Agents; Aspartate Carbamoyltransferase; Aspartic Acid; Binding Sites; Cytidine Triphosphate; Escherichia coli; Kinetics; Nucleotides; Organophosphorus Compounds; Phosphonoacetic Acid; Thermodynamics | 1985 |
Design and synthesis of new transition-state analogue inhibitors of aspartate transcarbamylase.
Topics: Antimetabolites, Antineoplastic; Aspartate Carbamoyltransferase; Aspartic Acid; Binding, Competitive; Carbamyl Phosphate; Chemical Phenomena; Chemistry; Kinetics; Organophosphorus Compounds; Organothiophosphorus Compounds; Phosphonoacetic Acid; Structure-Activity Relationship | 1985 |
Neurotoxicity of the pyrimidine synthesis inhibitor N-phosphonoacetyl-L-aspartate.
Topics: Adult; Aged; Animals; Antimetabolites, Antineoplastic; Aspartic Acid; Brain Diseases; Disease Models, Animal; Epilepsy; Female; Humans; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Rats; Rats, Inbred Strains; Seizures; Uridine | 1982 |
De novo pyrimidine nucleotide synthesis in the preimplantation mouse embryo.
Topics: Animals; Aspartate Carbamoyltransferase; Aspartic Acid; Blastocyst; Mice; Morula; Orotic Acid; Phosphonoacetic Acid; Pyrimidine Nucleotides; Uridine | 1981 |